Form 10-K BioXcel Therapeutics, For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260327/AJBEG22C8W22U2ZU222D2MZZEUKDZ2R2Z282
Filed on: March 27, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- How Furniture Dropshipping Suppliers Are Transforming Online Retail
- RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention
- TECNO Showcases Expanded EllaClaw Capabilities, Advancing Practical Agentic AI that Gets Things Done
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
